Hyundai Bio Hits Limit-Up, HLB Life Science Climbs on FDA NDA Plan[K-Bio Pulse] 송영두 2025.07.13 오전 09:50 Ildong Joins Obesity Drug Race; Alteogen Floats KOSPI Relisting[K-Bio Pulse] 임정요 2025.07.08 오전 07:59 Hyundai Bioscience vows to license out Korea’s first antiviral 유진희 2025.05.19 오전 09:02 HyundaiBio begins global trials of universal antiviral drug 유진희 2025.04.23 오후 04:28 Hyundai Bioscience Initiates Global Phase 2/3 Trial of COVID-19 Treatment Xafty 유진희 2025.05.23 오후 02:08 로딩중..